The sales of Danish Lundbeck's newest products make for brighter times for the company. However, the work to expand the pipeline via more late-phase acquisitions continues but not at any cost, says CEO Deborah Dunsire.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.